爱爱医资源-血脂异常老年人使用他汀类药物中国专家共识

万方数据

血脂异常老年人使用他汀类药物中国专家共识

作者：血脂异常老年人使用他汀类药物中国专家共识组

作者单位：

刊名：

中华内科杂志

英文刊名：CHINESE JOURNAL OF INTERNAL MEDICINE

年，卷(期)：2010,49(6)

参考文献(36条)

1.中国成人血脂异常防治指南制定联合委员会中国成人血脂异常防治指南 2007

2.He J;Cu D;Reynolds K Serum total and lipoprotein cholesterol levels and awareness,treatment,and control of hypercholesterolemia in China[外文期刊] 2004(4)

3.Wilson PW;D'Agostino RB;Levy D Prediction of coronary heart disease using risk factor categories 1998

4.Shepherd J;Blauw GJ;Murphy MB Pravastatin in elderly individuals at risk of vascular

disease(PROSPER):a randomised controlled trial 2002

5.Ye P;Lu ZL;Du BM Effect of xuezhikang on cardiovascular events and mortality in elderly patients with a history of myocardial infarction;a subgroup analysis of elderly subjects from the china coronary secondary prevention study 2007

6.Lemaitre RN;Psaty BM;Heckbert SR Therapy with hydroxymethylglutaryl coenzyme a reductase

inhibitors (statins)and associated risk of incident cardiovascular events in older adults;evidence from the Cardiovascular Health Study 2002

7.Sever PS;Dahl(o)f B;Poulter NR Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):a multicentre randomised controlled trial 2003

8.Shalev V;Chodick G;Silber H Continuation of statin treatment and all-cause mortality:a population-based cohort study.Arch Intern Med,2009,169:260-268.heart disease are equal to or exceed those seen in younger patients:Results from the LIPID trial 2001

9.Feldman T;Davidson M;Shah A Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia:a post Hoc analysis of subpopulations from three pooled clinical trials 2006 10.Huskey J;Lindenfeld J;Cook T Effect of simvastatin on kidney function loss in patients with coronary heart disease:findings from the Scandinavian Simvastatin Survival Study (4S) 2009

11.Afilalo J;Duque G;Steele R Statins for secondary prevention in elderly patients;a hierarchical bayesian meta-analysis 2008

12.Kjekshus J;Apetrei E;Barrios V Rosuvastatin in older patients with systolic heart failure[外文期刊] 2007

13.Cholesterol Treatment Trialists' (CTT) Collaborators;Kearney PM;Blackwell L Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins:a meta-analysis 2008

14.Neil HA;DeMicco DA;Luo D Analysis of efficacy and safety in patients aged 65-75 years at randomization;Collaborative Atorvastatin Diabetes Study (CARDS) 2006

15.Collins R;Armitage J;Parish S MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes;a randomized placebo-controlled trial 2003

16.Downs JR;Clearfield M;Weis S Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels; results of AFCAPS/TexCAPS.Air Force/Texas Coronary Atherosclerosis Prevention Study 1998

17.Tikhonoff V;Casiglia E;Mazza A Low-density lipoprotein cholesterol and mortality in older people 2005

18.Al-Omran M;Mamdani MM;Lindsay TF Suboptimal use of statin therapy in elderly patients with atherosclerosís:a population-based study 2008

19.Mizuno K;Nakaya N;Ohashi Y Usefulness of pravastatin in primary prevention of cardiovascular events in women;analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA study) 2008

20.Goldstein LB;Amarenco P;Szarek M Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study 2008(24 Pt 2)

21.The Stroke Prevention by Aggressive Reduction in Cholesterol Levels(SPARCL) Investigators High-dose atorvastatin after stroke or transient ischemic attack 2006

22.Heart Protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions 2004

23.Ray KK;Bach RC;Cannon CP Benefits of achieving the NCEP optional LDL-C goal among elderly

patients with ACS 2006

24.Cannon CP;Braunwald E;McCabe CH Intensive versus moderate lipid lowering with statins after acute coronary syndromes 2004

25.de Lemos JA;Blazing MA;Wiviott SD Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes;phase Z of the A to Z trial 2004

26.Olsson AC;Schwartz GG;Szarek M Effects of high-dose atorvastatin in patients > or =65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering[MIRACL] study) 2007

27.Deedwania P;Stone PH;Bairey Mere CN Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease;results of the Study Assessing Goals in the Elderly (SAGE) 2007

28.Wenger NK;Lewis SJ;Herrington DM Outcomes of using high-or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease 2007

29.Pedersen TR;Faergeman O;Kastelein JJ High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction;the IDEAL study:a randomized controlled trial 2005 30.Heart Protection Study Collaborative Group The effects of cholesterol lowering with simvastatin

on cause-specific mortality and on cancer incidence in 20,536 high-risk people;a randomised placebo-controlled trial 2005

31.Hunt D;Young P;Simes J Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients:Results from the LIPID trial 2001

32.Lewis SJ;Moye LA;Sacks FM Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range.Results of the Cholesterol and Recurrent Events(CARE) trial 1998

33.Miettinen TA;Pybrala K;Olsson AG Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris:findings from the Scandinavian Simvastatin Survival

Study(4S) 1997

34.Ridker PM;Danielson E;Fonseca FA Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein[外文期刊] 2008(21)

35.Mehta JL;Bursac Z;Hauer-Jensen M Comparison of mortality rates in statin users versus nonstatin users in a United States veteran population 2006

36.Pilote L;Beck CA;Karp I Secondary prevention after acute myocardial infarction in four Canadian provinces,1997-2000 2004

本文读者也读过(10条)

1.中国医师协会心血管内科医师分会.中国老年学学会心脑血管病专业委员会胆固醇吸收抑制剂临床应用中国专家共识[期刊论文]-中华内科杂志2010,49(6)

2.缺血性卒中/短暂性脑缺血发作血糖管理的中国专家共识组缺血性卒中/短暂性脑缺血发作血糖管理的中国专家共识[期刊论文]-中华内科杂志2010,49(4)

3.中国医师协会心血管内科医师分会.中国老年学学会心脑血管病专业委员会.中国医师协会循证医学专业委员会依诺肝素在急性冠状动脉综合征抗凝治疗的中国专家共识[期刊论文]-中华内科杂志2010,49(1)

4.中华医学会心血管病学分会肺血管病学组.中国医师协会心血管内科医师分会急性肺血栓栓塞症诊断治疗中国专家共识[期刊论文]-中华内科杂志2010,49(1)

5.抗血小板药物消化道损伤的预防和治疗中国专家共识组抗血小板药物消化道损伤的预防和治疗中国专家共识[期刊论文]-中华内科杂志2009,48(7)

6.急性冠状动脉综合征非血运重建患者抗血小板治疗中国专家共识组急性冠状动脉综合征非血运重建患者抗血小板治疗的中国专家共识(修订案)[期刊论文]-中华内科杂志2009,48(9)

7.急性ST段抬高心肌梗死溶栓治疗中国专家共识组急性ST段抬高心肌梗死溶栓治疗中国专家共识(2009年版)[期刊论文]-中华内科杂志2009,48(10)

8.中国医师协会心血管内科医师分会.中国老年学学会心脑血管病专业委员会苯磺酸左旋氨氯地平临床应用专家共识[期刊论文]-中华内科杂志2010,49(11)

9.中国医师协会心血管内科医师分会.《中华内科杂志》编辑委员会心血管疾病一级预防中国专家共识[期刊论文]-中华内科杂志2010,49(2)

10.老年高血压诊断与治疗中国专家共识组老年高血压诊断与治疗2008中国专家共识[期刊论文]-中华内科杂志2008,47(12)

本文链接：https://www.360docs.net/doc/212748527.html,/Periodical_zhnk201006029.aspx